Molina Healthcare, Inc. (NYSE:MOH) Shares Acquired by Russell Investments Group Ltd.

Russell Investments Group Ltd. lifted its position in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 13.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 116,455 shares of the company's stock after purchasing an additional 13,850 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.20% of Molina Healthcare worth $33,885,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Waldron Private Wealth LLC boosted its holdings in shares of Molina Healthcare by 4.7% in the fourth quarter. Waldron Private Wealth LLC now owns 729 shares of the company's stock valued at $212,000 after acquiring an additional 33 shares during the period. Angeles Investment Advisors LLC boosted its stake in Molina Healthcare by 5.4% during the 4th quarter. Angeles Investment Advisors LLC now owns 838 shares of the company's stock worth $244,000 after purchasing an additional 43 shares during the period. HighTower Advisors LLC boosted its stake in Molina Healthcare by 2.1% during the 3rd quarter. HighTower Advisors LLC now owns 2,627 shares of the company's stock worth $906,000 after purchasing an additional 55 shares during the period. Lindbrook Capital LLC grew its position in Molina Healthcare by 38.5% during the 4th quarter. Lindbrook Capital LLC now owns 205 shares of the company's stock worth $60,000 after purchasing an additional 57 shares during the last quarter. Finally, Brooklyn Investment Group increased its stake in Molina Healthcare by 20.1% in the fourth quarter. Brooklyn Investment Group now owns 400 shares of the company's stock valued at $116,000 after purchasing an additional 67 shares during the period. Hedge funds and other institutional investors own 98.50% of the company's stock.

Remove Ads

Molina Healthcare Price Performance

MOH stock traded up $2.62 during trading on Friday, reaching $345.30. 661,970 shares of the company were exchanged, compared to its average volume of 654,682. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $373.22. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The company has a market cap of $18.89 billion, a P/E ratio of 16.90, a PEG ratio of 1.06 and a beta of 0.70. The stock's 50 day moving average price is $310.39 and its 200 day moving average price is $307.97.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. As a group, analysts predict that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Insider Activity

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.10% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. JPMorgan Chase & Co. reissued a "neutral" rating and set a $350.00 price target (down previously from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Wells Fargo & Company upgraded Molina Healthcare from an "equal weight" rating to an "overweight" rating and lifted their target price for the company from $295.00 to $372.00 in a research note on Wednesday, March 5th. Guggenheim began coverage on Molina Healthcare in a research note on Wednesday. They set a "neutral" rating for the company. Stephens reaffirmed an "equal weight" rating and set a $345.00 price target on shares of Molina Healthcare in a report on Thursday, February 6th. Finally, UBS Group dropped their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating on the stock in a research note on Friday, February 7th. Seven research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $355.75.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.